Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexU.S. General Services Administration, National Archives and Records Service, Office of the Federal Register, 1994 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
active ingredient addiction adequate amended Amyl nitrite animal appropriate approved batch beling cated feed chapter clinical cluding Code Cosmetic Act Department distribution distributor dosage form dose Drug Administration drug application drug components drug listing drug product containers equipment established name evaluation exemption Federal Acquisition Regulation Federal Food Federal Register Food and Drug gram Health hexachlorophene human intended labeling licensed maintenance treatment manufac manufacturing practice medi medicated article(s medicated feed ment narcotic narcotic drugs National new-drug application nitrite inhalant Office operations oral over-the-counter over-the-counter drug package Packaging and labeling paragraph patient patient's record pernicious anemia potassium permanganate pregnancy Pregnancy Category preparations prescription drug procedures processing program physician proprietary name quired regarded as misbranded reminder advertisement safety sample Service shipment side effects specific statement storage submitted tained testing thorium dioxide tion treatment program Type A medicated unit warning
Populāri fragmenti
19. lappuse - ProHance* should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
21. lappuse - Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Lortab 7.5/500 tablets, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
19. lappuse - There are. however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed...
40. lappuse - Indications Based on a review of this drug by the National Academy of Sciences— National Research Council and/or other information, FDA has classified the indications as follows: Effective: For the management of the manifestations of psychotic disorders.
33. lappuse - Labeling on or within the package from which the drug is to be dispensed bears adequate information for its use, including indications, effects, dosages, routes, methods, and frequency and duration of administration, and any relevant hazards, contraindications, side effects, and precautions...
21. lappuse - Nursing Mothers: It is not known whether this drug is excreted in human milk Because many drugs are excreted in human milk, caution should be exercised when sucralfate is administered to a nursing woman...
129. lappuse - XXIII Arctic Research Commission (Part 2301) XXIV James Madison Memorial Fellowship Foundation (Parts 2400— 2499) XXV Corporation for National and Community Service (Parts 2500— 2550) Chap.
19. lappuse - It is also not known whether Wellcovorin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
43. lappuse - The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed...
34. lappuse - If a shipment or delivery, or any part thereof, of a drug or device which Is exempt under the regulations in this section is made to a person in whose possession the article is not exempt, or is made for any purpose other than those specified, such exemption shall expire, with respect to such shipment or delivery or part thereof, at the beginning of that shipment or delivery. The causing of an exemption to expire shall be considered an act which results in such drug or device being misbranded unless...